Moreover, GLP-1R expression at VAT and SAT did not differ between patients remaining with T2D compared with those under partial or complete T2D remission after the bariatric procedure: 0.29 (0.04;0.82) vs. 1.05 (0.22;2.10) vs. 0.28 (0.08;2.18), p = 0.779 and 0.02 (0.0009;0.007) vs. 0.03 (0.0026;0.32) vs. 0.17 (0.01;0.37), p = 0.278, respectively (Fig. 3). This evidence concerns the gene GLP1R and type 2 diabetes mellitus.